Colchicine for Acute Coronary Syndromes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT01906749

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Maria Vittoria Hospital (from the registry)
Registry
  • NCT NCT01906749
  • EudraCT 2013-001415-78
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01906749. Randomized; quadruple masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2016-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine for Acute Coronary Syndromes
Acronym
COACS
Condition
Acute Coronary Syndrome
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
Maria Vittoria Hospital (class: other)

Record details

Record id
cardio:ct-nct01906749
Content hash
eaab461e4e31745b00bf098d6b512d5cfc9cfda7d45515ed8cda66111d2648e9